Clinical Trials Browser

Phase 2 × Medroxyprogesterone Acetate × 30 days × Clear all

NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms